Additional file 1 of Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

Additional file 1: Fig. S1. Study Design. Fig. S2. Mean change in SI joint bone marrow edema score by MRI in the overall population and in patients with baseline score >2 through week 104 (in patients with images available at all 4 time points). Table S1. Syndesmophyte status at screening by mNY status at screening based on single reader assessment and two reader agreement.